Clinical Edge Journal Scan

Diagnostic role of nailfold capillaroscopy for identifying PsA in psoriasis needs further investigation


 

Key clinical point: Nailfold capillaroscopy (NC) outcomes could not conclusively differentiate psoriasis from psoriatic arthritis (PsA).

Major finding: In addition to altered morphology, the density of capillaries at the nailfold was significantly lower in patients with psoriasis (standardized group difference [SMD] 0.91; P = .0058; area under curve [AUC] 0.740) and PsA (SMD 1.22; P = .0432; AUC, 0.806) compared with control individuals; however, no NC outcomes conclusively differentiated between psoriasis and PsA.

Study details: Findings are from a systematic review and meta-analysis of 22 studies investigating NC as a diagnostic tool for psoriasis or PsA.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Lazar LT et al. Nailfold capillaroscopy as diagnostic test in patients with psoriasis and psoriatic arthritis: A systematic review. Microvasc Res. 2023;147:104476 (Jan 16). Doi: 10.1016/j.mvr.2023.104476

Recommended Reading

Baseline cardiovascular risk may influence MACE and malignancy incidences in tofacitinib-treated PsA patients
Psoriatic Arthritis ICYMI
Long-term safety and tolerability of upadacitinib in PsA
Psoriatic Arthritis ICYMI
PsA: Baseline disease activity predicts DAPSA response in patients treated with apremilast
Psoriatic Arthritis ICYMI
PsA prediction tool approaches clinical utility
Psoriatic Arthritis ICYMI
Are repeat radiographs necessary in rheumatoid and psoriatic arthritis?
Psoriatic Arthritis ICYMI
What’s holding back physicians from prescribing biosimilars? Four specialties weigh in
Psoriatic Arthritis ICYMI
Isolated nail psoriasis may bring arthritis into play
Psoriatic Arthritis ICYMI
Commentary: Concerning PsA treatments and comorbidities, March 2023
Psoriatic Arthritis ICYMI
PsA: Guselkumab demonstrates consistent safety profile irrespective of prior TNFi exposure
Psoriatic Arthritis ICYMI
Psoriatic arthritis: An independent risk factor for reduced bone density and fractures
Psoriatic Arthritis ICYMI